Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 28 M18 M9 M18 M35 M 80 M Research & development ————— — Operating income 295 M308 M434 M132 M350 M 1.22 B Non-Operating Income, Total 526 M543 M582 M557 M525 M 2.21 B Interest expense, net of interest capitalized 67 M63 M60 M146 M61 M 330 M Non-Operating Income, excl. Interest Expenses 459 M480 M522 M411 M464 M 1.88 B Unusual income/expense ————— — Pretax income 173 M188 M307 M169 M230 M 894 M Equity in earnings ————— — Taxes 22 M27 M35 M20 M35 M 117 M Non-controlling/minority interest -5 M-5 M80 M9 M13 M 97 M After tax other income/expense ————— — Net income before discontinued operations 156 M166 M192 M140 M182 M 680 M Discontinued operations ————— — Net income 156 M166 M192 M140 M182 M 680 M Dilution adjustment 00000 0 Preferred dividends 17 M4 M16 M4 M17 M 41 M Diluted net income available to common stockholders 139 M162 M176 M136 M165 M 639 M Basic earnings per share (Basic EPS) 1.451.691.821.441.78 6.73 Diluted earnings per share (Diluted EPS) 1.421.661.81.411.75 6.62 Average basic shares outstanding 95.9 M96.4 M95.9 M95.8 M93.1 M — Diluted shares outstanding 97.8 M97.7 M97.4 M97.4 M94.5 M — EBITDA 335 M373 M525 M402 M393 M 1.69 B EBIT 295 M308 M434 M132 M350 M 1.22 B Cost of revenue 850 M816 M865 M1.04 B833 M 3.56 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 40 M65 M91 M270 M43 M 469 M